Literature DB >> 19682818

EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase.

Oliver Bruder1, Steffen Schneider, Detlef Nothnagel, Thorsten Dill, Vinzenz Hombach, Jeanette Schulz-Menger, Eike Nagel, Massimo Lombardi, Albert C van Rossum, Anja Wagner, Juerg Schwitter, Jochen Senges, Georg V Sabin, Udo Sechtem, Heiko Mahrholdt.   

Abstract

OBJECTIVES: During its German pilot phase, the EuroCMR (European Cardiovascular Magnetic Resonance) registry sought to evaluate indications, image quality, safety, and impact on patient management of routine CMR.
BACKGROUND: CMR has a broad range of applications and is increasingly used in clinical practice.
METHODS: This was a multicenter registry with consecutive enrollment of patients in 20 German centers.
RESULTS: A total of 11,040 consecutive patients were enrolled. Eighty-eight percent of patients received gadolinium-based contrast agents. Twenty-one percent underwent adenosine perfusion, and 11% high-dose dobutamine-stress CMR. The most important indications were workup of myocarditis/cardiomyopathies (32%), risk stratification in suspected coronary artery disease/ischemia (31%), as well as assessment of viability (15%). Image quality was good in 90.1%, moderate in 8.1%, and inadequate in 1.8% of cases. Severe complications occurred in 0.05%, and were all associated with stress testing. No patient died during or due to CMR. In nearly two-thirds of patients, CMR findings impacted patient management. Importantly, in 16% of cases the final diagnosis based on CMR was different from the diagnosis before CMR, leading to a complete change in management. In more than 86% of cases, CMR was capable of satisfying all imaging needs so that no further imaging was required.
CONCLUSIONS: CMR is frequently performed in clinical practice in many participating centers. The most important indications are workup of myocarditis/cardiomyopathies, risk stratification in suspected coronary artery disease/ischemia, and assessment of viability. CMR imaging as used in the centers of the pilot registry is a safe procedure, has diagnostic image quality in 98% of cases, and its results have strong impact on patient management.

Entities:  

Mesh:

Year:  2009        PMID: 19682818     DOI: 10.1016/j.jacc.2009.07.003

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  56 in total

1.  Extracardiac findings detected by cardiac magnetic resonance imaging.

Authors:  Rolf Wyttenbach; Nathalie Médioni; Paolo Santini; Peter Vock; Zsolt Szucs-Farkas
Journal:  Eur Radiol       Date:  2012-01-04       Impact factor: 5.315

2.  Value of cardiovascular magnetic resonance imaging in myocardial hypertrophy.

Authors:  Andreas Schuster; Masaki Ishida; Geraint Morton; Boris Bigalke; Mufaddal T Moonim; Eike Nagel
Journal:  Clin Res Cardiol       Date:  2012-01-03       Impact factor: 5.460

3.  The incremental impact of cardiac MRI on clinical decision-making.

Authors:  Adil Rajwani; Michael J Stewart; James D Richardson; Nicholas M Child; Neil Maredia
Journal:  Br J Radiol       Date:  2015-10-23       Impact factor: 3.039

4.  Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane A Vido-Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Douglas Mc Nair; Robert W Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

5.  Automatic high-resolution infarct detection using volumetric multiphase dual-energy CT.

Authors:  Veit Sandfort; Alan C Kwan; Comfort Elumogo; Davis M Vigneault; Rolf Symons; Amir Pourmorteza; Kelly Rice; Cynthia Davies-Venn; Mark A Ahlman; Chia-Ying Liu; Stefan L Zimmerman; David A Bluemke
Journal:  J Cardiovasc Comput Tomogr       Date:  2017-04-18

6.  Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.

Authors:  Lian-Ming Wu; Bing-Hua Chen; Qiu-Ying Yao; Yang-Rongzheng Ou; Rui Wu; Meng Jiang; Jiani Hu; Dong-Aolei An; Jian-Rong Xu
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-19       Impact factor: 2.357

7.  [Cardiomyopathies and myocarditis].

Authors:  F von Knobelsdorff-Brenkenhoff; J Schulz-Menger
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

8.  Lessons Learned from the European Cardiovascular Magnetic Resonance (EuroCMR) Registry Pilot Phase.

Authors:  Oliver Bruder; Anja Wagner; Heiko Mahrholdt
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-04-13

Review 9.  Current cardiac imaging techniques for detection of left ventricular mass.

Authors:  Aksuyek S Celebi; Hulya Yalcin; Fatih Yalcin
Journal:  Cardiovasc Ultrasound       Date:  2010-06-01       Impact factor: 2.062

Review 10.  T2-weighted cardiovascular magnetic resonance in acute cardiac disease.

Authors:  Ingo Eitel; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2011-02-18       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.